What is Harvard MedTech?
Harvard MedTech is an innovative company focused on transforming trauma recovery through its virtual reality platform, Vx Therapy. This platform is designed to manage pain, anxiety, depression, sleep disruption, and PTSD-related symptoms, offering holistic and non-invasive healing for both the mind and body. With a decade of research, Vx Therapy has achieved a 96% satisfaction rate among physicians and patients, with over 4,500 individuals utilizing the service for emotional and physical healing. The company partners with leading organizations to continuously enhance the Vx Therapy platform, aiming to improve the lives of those affected by trauma.
How much funding has Harvard MedTech raised?
Harvard MedTech has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Harvard MedTech
PPP
Public-Private Partnership
What's next for Harvard MedTech?
The substantial capital infusion, particularly the recent strategic investment, positions Harvard MedTech for significant scaling and further development of its groundbreaking Vx Therapy platform. This late-stage funding suggests a focus on market expansion, broader clinical adoption, and potentially new therapeutic applications. The company's proven efficacy and high satisfaction rates indicate a strong trajectory for continued growth and impact in the mental health and trauma recovery sector.
See full Harvard MedTech company page
